Physician
Hematology
Dr. Jay N. Lozier, MD
Lozier practices Hematology. Doctor Jay N. Lozier, MD is a published doctor and has 43 publications published. The lastest was: 'Gut epithelial cells as targets for gene therapy of hemophilia.'
Publications
- York platelet syndrome is a CRAC channelopathy due to gain-of-function mutations in STIM1.
- The intron-22-inverted F8 locus permits intracellular factor VIII synthesis, explaining its low inhibitor risk and suggesting a role for pharmacogenomics.
- Inhibitory effect of nitrite on coagulation processes demonstrated by thrombelastography.
- Recombinant Human Factor VIIa for Alveolar Hemorrhage Following Allogeneic Stem Cell Transplantation.
- Acquired haemophilia A after stem cell transplant for sickle cell disease: treatment with recombinant porcine factor VIII (OBI-1) and tolerance induction with rituxima...
- Animal Models of Hemophilia and Related Bleeding Disorders.
- Elevations in D-dimer and C-reactive protein are associated with the development of osteonecrosis of the hip in HIV-infected adults.
- Treatment of high-risk venous thrombosis patients using low-dose intraclot injections of recombinant tissue plasminogen activator and regional anticoagulation.
- Familial secondary erythrocytosis due to increased oxygen affinity is caused by destabilization of the T state of hemoglobin Brigham (α(2) β(2) (Pro100Leu) ).
- Eltrombopag and improved hematopoiesis in refractory aplastic anemia.
- Gene therapy for haemophilia: prospects and challenges to prevent or reverse inhibitor formation.
- Spray: single-donor plasma product for room temperature storage.
- Low-Dose, Once-Daily, Intraclot Injections of Alteplase for Treatment of Acute Deep Venous Thrombosis.
- Thromboembolic adverse events after use of recombinant human coagulation factor VIIa.
- Rapid Kupffer cell death after intravenous injection of adenovirus vectors.
- Mapping of genes that control the antibody response to human factor IX in mice.
- Severe pulmonary pathology after intravenous administration of vectors in cirrhotic rats.
- The Chapel Hill hemophilia A dog colony exhibits a factor VIII gene inversion.
- Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques.
- Toxicity of a first-generation adenoviral vector in rhesus macaques.
- Adenoviral vectors do not induce, inhibit, or potentiate human platelet aggregation.
- Complete amino acid sequence of human plasma beta 2-glycoprotein I.
- Safety profile of porcine factor VIII and its use as hospital and home-therapy for patients with haemophilia-A and inhibitors: the results of an international survey.
- New perspectives on the coagulation cascade.
- Porcine factor VIII therapy in patients with congenital hemophilia and inhibitors: efficacy, patient selection, and side effects.
- Molecular basis of hemophilia.
- Haemophilia B: database of point mutations and short additions and deletions.
- Use of porcine factor VIII for surgical procedures in hemophilia A patients with inhibitors.
- Clinical and molecular characterization of a re-established line of sheep exhibiting hemophilia A.
- Gene therapy of the hemophilias.
- Thrombocytopenia and hemostatic disorders in chronic graft versus host disease.
- Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment.
- A case-control study reveals immunoregulatory gene haplotypes that influence inhibitor risk in severe haemophilia A.
- Gene therapy and the hemophilias.
- Interleukin-2 cycling causes transient increases in high-sensitivity C-reactive protein and D-dimer that are not associated with plasma HIV-RNA levels.
- Factor IX New London: substitution of proline for glutamine at position 50 causes severe hemophilia B.
- Efficient transfection of primary cells in a canine hemophilia B model using adenovirus-polylysine-DNA complexes.
- Gut epithelial cells as targets for gene therapy of hemophilia.
- The rhesus macaque as an animal model for hemophilia B gene therapy.
- Intravenous administration of replication-incompetent adenovirus to rhesus monkeys induces thrombocytopenia by increasing in vivo platelet clearance.
- Adenovirus-mediated expression of human coagulation factor IX in the rhesus macaque is associated with dose-limiting toxicity.
- Paraneoplastic granulocytosis in metastatic melanoma.
Schools
Indiana University School of Medicine
Doctors Specialties
- Hematology
Accepted Insurances
Education
-
University of North Carolina Hospitals
Helpful Reviews
Similar Doctors
|
Shivaani R. Kummar, MB
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Steven Z. Pavletic, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Jeremy G. Perkins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel Godwin Wright, MD |
|
|
Dr. Phillip Scheinberg, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Charles D. Bolan Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Minocher M. Battiwalla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sanjeeve Balasubramaniam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert M. Post, MD |
|
|
Dr. Morteza Moussavi, MD |
|
|
Dr. Thomas M. Herndon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shakuntala M. Malik, MD |
|
|
Dr. Matthew M. Hsieh, MD
This Doctor is OpenDoctor Recommended.
|